Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Subcutaneous Orencia available for patients 2 years of age and older

June 9, 2017

Bristol-Myers Squibb patents TYK2 inhibitors

June 8, 2017

BAMBI inhibition is beneficial in autoimmune diseases

May 31, 2017

FDA approves Kevzara for rheumatoid arthritis

May 23, 2017

Emmyon patents new furostan-3-ol derivatives

May 23, 2017

ALX-1141 to enter clinical development for the treatment of osteoarthritis

May 23, 2017

Articular cartilage product granted positive opinion from CHMP for European approval

May 22, 2017

EMA accepts for review MAA for adalimumab biosimilar, FKB-327

May 22, 2017

Symic reports topline results from phase I/IIa study of SB-061 for osteoarthritis of the knee

May 19, 2017

Development of cell-mediated gene therapy Invossa updated at ASCGT

May 16, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...